address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,enterpriseToEbitda,52WeekChange,SandP52WeekChange,quoteType,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,returnOnAssets,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,corporateActions,regularMarketChangePercent,regularMarketPrice,shortName,longName,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,regularMarketTime,marketState,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,epsTrailingTwelveMonths,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,priceToBook,sourceInterval,exchangeDataDelayedBy,prevName,nameChangeDate,cryptoTradeable,hasPrePostMarketData,firstTradeDateMilliseconds,trailingPegRatio
Scheelev√§gen 27,Lund,223 63,Sweden,46 4 62 86 54 00,https://www.magnasense.com,Medical Devices,medical-devices,Medical Devices,Healthcare,healthcare,Healthcare,"Magnasense AB develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs. The company develops a testing platform for oral health, therapeutic drug monitoring, and infectious diseases. It develops Veritope technology used to optimize the dosage of biological drugs to patients; and the MagniaReader platform. The company was formerly known as AegirBio AB (publ) and changed its name to Magnasense AB in July 2024. Magnasense AB was incorporated in 2019 and is based in Lund, Sweden.",15,"[{'maxAge': 1, 'name': 'Mr. Marco  Witteveen', 'age': 55, 'title': 'CEO & Director', 'yearBorn': 1969, 'fiscalYear': 2024, 'totalPay': 2980000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Vicki  Johnson', 'age': 40, 'title': 'Interim Chief Financial Officer', 'yearBorn': 1984, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Vasiliki  Fragkou', 'age': 45, 'title': 'Chief Operating Officer', 'yearBorn': 1979, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,4,0.0058,0.0063,0.004,0.012,0.0058,0.0063,0.004,0.012,0.0,2.366,1045876196,1045876196,74772445,229257915,229257915,0.0098,0.0099,18619900,0.0022,0.4295,0.032874,0.120659,0.0,0.0,SEK,False,46924020,0.0,62159905,1861990016,0.0024899999,0.00065,2234380032,-0.62,1735603200,1767139200,1735603200,-49632000,-0.16,-3.378,-0.975,0.12969577,EQUITY,0.01,none,283000,0.005,-13892000,47020000,0.291,0.316,-0.40081,-19352376,-12132000,0.0,0.0,0.0,SEK,MAGNA.ST,en-US,US,Equity,Delayed Quote,True,HIGH,[],72.41379,0.01,Magnasense AB,Magnasense AB,STO,finmb_653904512,Europe/Stockholm,CEST,7200000,se_market,False,1752679797,PREPRE,0.0042,0.004 - 0.012,Stockholm,74772445,0.0078,3.5454545,0.0022 - 0.4295,-0.41950002,-0.9767171,-97.5,-0.16,-0.022874,-0.69580823,-0.110659,-0.9171218,-0.016129032,15,0,AegirBio AB (publ),2025-07-16,False,False,1719903600000,
